Search by Drug Name or NDC
NDC 70000-0247-01 Leader Migraine Relief 250; 250; 65 mg/1; mg/1; mg/1 Details
Leader Migraine Relief 250; 250; 65 mg/1; mg/1; mg/1
Leader Migraine Relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health 110, LLC. dba Leader. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 70000-0247 |
|---|---|
| Product ID | 70000-0247_db3fd8b0-2223-4bb1-89e7-62391d9b341a |
| Associated GPIs | 64990003200350 |
| GCN Sequence Number | 040186 |
| GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 10414 |
| HICL Sequence Number | 001807 |
| HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Generic |
| Proprietary Name | Leader Migraine Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetaminophen, Aspirin, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | Cardinal Health 110, LLC. dba Leader |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075794 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70000-0247-01 (70000024701)
| NDC Package Code | 70000-0247-1 |
|---|---|
| Billing NDC | 70000024701 |
| Package | 1 BOTTLE in 1 CARTON (70000-0247-1) / 24 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2017-02-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.06567 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | MIGRAINE 250-250-65 MG CPLT |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis